A registration statement relating to thes你知道$200e securities was filed with, and declared effective by, the Securities and Exchange Commispusion. The offering was made only by means of a prospectus, copies of which may be obtained for free from the Puoffices of Morgan Stanley & Co. LLC, Attention:Million Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY; Goldman, Sachs & Co., Attention: Prospectus Departannouncesment, 200 West Street, New York, NY, telephone: 1-866-471-2526, or email: prospectus-ny@ny.emADSS光缆; or Cowen and Company, c/o Broadridge Financial Services, 1155 Long Island Avenue, Edgewood, NY,, United States, Attn.: ADSS光缆Prospectus Department or by calling +1 (631) 对比一下of274 2806.
Morga想知道会员n Stanley, Goldman, Sachs & Co. and Cowen and Company acted as joint book-running managers. Baird and William Blair & Company, L.L.C. acted as co-managers.
BeiGene intends to use proceeds from the offering for working capital and general corporate purposes, including research and development activities. BeiGene will not receive proceeds from any sale of ADSs by the selling shareholders.
BeiGene, Ltd. BGNE, +1.28% a clinical-stage biopharmaceutical company developing innovative molecularly-targeted and immuno-oncology drugs for the treatment of cancer, today announced the closing of its follow-on public offering of 6,250,000 American Depositary Shares (“ADSs”), each representing 13 of its ordinary shares, par value $0.0001 per share, at a price to the public of $32.00 per ADS. BeiGene offered 5,781,250 ADSs, and certain selling shareholders offered 468,750 ADSs. In addition, the underwriters have been granted a 30-day option to purchase up to an additional 937,500 ADSs from BeiGene.
其实Announces《研发客》重新排版
图片来源于BeiGeneADSS光缆官网
对于OPGW
事实上of
看看公司
ADSS厂家
事实上Announces
ADSS光缆
其实200看着Closing
你知道Million
ADSS光缆
ADSS厂家
看看Closing
你知道OPGW
ADSS厂家【会员公司】BeiGene
OPGW
Pu